Whalesbook
This negative outlook is rooted in a fundamental shift in the company's capital allocation strategy, which has increasingly favored ventures outside its traditional strengths. The market's reaction saw the stock trading at ₹2,856.70 on Wednesday morning, a modest gain that belies the underlying concerns raised by the new analyst coverage.
The Diversification Dilemma
The core of the bearish thesis is Thermax's aggressive push into non-core segments. According to JM Financial, capital is being funneled into solar assets, bio-energy, and chemicals—businesses that deliver a Return on Capital Employed (ROCE) between 0-5%. This stands in stark contrast to the company's blended ROCE of over 10%, indicating a significant drag on overall profitability. This strategic shift towards an asset-heavy solar model is also projected to pressure the company's balance sheet, with net cash expected to decline from ₹13 billion in FY25 to ₹12 billion by FY28E, even as earnings are forecast to grow.
Valuing a Segmented Behemoth
JM Financial's valuation approach avoids a simple price-to-earnings multiple, arguing that the varied risk profiles of Thermax's segments demand a more granular sum-of-the-parts (SotP) analysis. The resulting ₹2,700 target price implies an aggregate P/E of 32x, a slight de-rating from its current market valuation. A glance at the competitive landscape shows Thermax trading at a high P/E of approximately 57. This is significantly higher than industrial conglomerate Larsen & Toubro's P/E of about 33-36 but more in line with Siemens India, which trades at a P/E of around 44-49. State-run competitor BHEL trades at a much higher P/E of over 100, reflecting different market dynamics. This premium valuation for Thermax may be difficult to sustain if the lower-margin businesses continue to expand without a clear path to higher profitability.
The Forward-Looking Balance Sheet
Analysts express caution regarding the assumptions underpinning future margin recovery. The brokerage factors in a normalization of industrial infrastructure EBIT margins to 6% by FY28 from 3% in FY25, and a chemical margin improvement to 14% from 12%. However, these targets are considered ambitious given the company's execution track record and a challenging macro environment for specialty chemicals, where global production growth is forecast to be a muted 1.5-2.0% in 2026. While the Indian government's focus on capital expenditure in the upcoming budget could provide a tailwind for the broader sector, JM Financial is not optimistic about a near-term domestic industrial capex recovery. The consensus among a wider group of analysts remains more positive, with an average price target of ₹3,384, suggesting JM Financial's view is currently on the more pessimistic end of the spectrum.